Healthcare & Life Sciences
Avilar Therapeutics
United Stateswww.avilartx.com/
Avilar Therapeutics is a seed startup based in United States. 2 investors tracked. Status: acquired.
Acquiredseries-c-plus
series-c-plus
Stage
2020
Founded
3
Investors
About Avilar Therapeutics
Based in the United States, Avilar Therapeutics is a startup founded in 2020. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in medicine. The company is developing ATACs (ASGPR Targeting Chimeras), a new class of protein degraders that are designed to remove disease-causing proteins from circulation.
Explore Avilar Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.